Pfizer Denied Interlocutory Appeal In Pay-For-Delay MDL
By Dan Prochilo ( September 10, 2013, 9:01 PM EDT) -- A Tennessee federal judge Tuesday rejected a bid by Pfizer Inc.'s King Pharmaceuticals LLC and Mutual Pharmaceutical Co. to appeal his finding that antitrust claims accusing them of blocking the release of a generic version of the drug Skelaxin were exempt from the statute of limitations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.